| --- | --- | --- | --- | |--------------------------------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | The Essential Biodata Life Science Partner in | | | | | Rare and | | | | | | | | | | Neurodegenerative Diseases | | | | | H.C. Wainwright 24 th Annual Global Investment Conference | | | | | CENTOGENE NV (NASDAQ: CNTG) September 12, 2022 - New York | | | | | Presenter: Kim Stratton, CEO | | | | Safe Harbour and Disclaimer Statement This presentation has been prepa ...